A Brief Introduction to the Research Progress of Vaccine Adjuvants (Part 2)
Adjuvants, also known as immunomodulators or immune enhancers, are additives used in vaccines.
September 2, 2025
by Xiaonisha
Research Progress on Therapeutic Human Papillomavirus (HPV) Vaccines
Currently, the research and development technology for prophylactic human papillomavirus (HPV) vaccines is becoming increasingly mature (related reading: "Current Status of Research and Application of Prophylactic Human Papillomavirus (HPV) Vaccines").
July 23, 2025
by Xiaomichong
Pharmaceutical Business in China and Worldwide (October)(2023)
Pharmaceutical companies sign cooperation agreements with research laboratories to provide commercialization of drug products.
November 1, 2023
by PharmaSources
FDA Issues Final Guidance on Bispecific Antibody Development Programs
The U.S. FDA issued a final guidance on Bispecific Antibody Development Programs. This final guidance provides recommendations for industry and other parties involved in developing bispecific antibodies, which are antibody-based products that target ...
May 26, 2021
by americanpharmaceuticalreview
Cipla launches rapid antigen detection test to diagnose COVID-19
Cipla announced its partnership with the Premier Medical Corporation for commercialisation of the rapid antigen test kits for COVID-19 in India. The company will commence supply from this week.
December 16, 2020
by expresspharma
Genocea armed with positive phase 2b data on potential blockbuster herpes vax
Genocea’s therapeutic genital herpes vaccine posted new phase 2b data that support the candidate's "groundbreaking potential" as possibly the first genital herpes treatment advancement in more than 20 years, the biotech's CEO says.
January 11, 2017
by fiercepharma